← Eichor
Condition: Multiple Sclerosis Ms Primary Progressive Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Multiple Sclerosis Ms Primary Progressive

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcuta
Phase 1 · 12 location(s) · Hoffmann-La Roche · NCT07667322A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Phase 3 · 40 location(s) · Zenas BioPharma (USA), LLC · NCT07067463A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Fo
Phase 1 · 1 location(s) · Stanford University · NCT06138132"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
Phase N/A · 1 location(s) · University of California, San Francisco · NCT07222618Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT05177523MS-ResearchBiomarkerS
Phase N/A · 1 location(s) · Cedars-Sinai Medical Center · NCT05204459Definition of Autonomic Nervous System Involvement in Patients With Multiple Sclerosis
NA · 2 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT05748015Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
Phase 1/Phase 2 · 1 location(s) · University of California, San Francisco · NCT05359653A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Phase 1 · 8 location(s) · TG Therapeutics, Inc. · NCT06680037Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
Phase 1/Phase 2 · 2 location(s) · Tr1X, Inc. · NCT07477639Home Based Functional Balance Intervention for Multiple Sclerosis
NA · 1 location(s) · University of Illinois at Chicago · NCT07355387NYSCF Scientific Discovery Biobank
Phase N/A · 1 location(s) · New York Stem Cell Foundation Research Institute · NCT06203106Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis
Phase 1 · 2 location(s) · Rennes University Hospital · NCT06592703Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis
Phase N/A · 2 location(s) · Heinrich-Heine University, Duesseldorf · NCT07426991Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Phase 1 · 1 location(s) · Polina Stepensky · NCT07085676SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis
Phase 1 · 1 location(s) · Queen Mary University of London · NCT03783416Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT06526364Neurologic Stem Cell Treatment Study
NA · 3 location(s) · MD Stem Cells · NCT02795052
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.